A critical growth driver for most any central laboratory is its ability to gain preferred provider agreements (PPAs): becoming a vendor that has achieved priority status in the award of contracts by a biopharmaceutical company. Whether leading an emerging, mid-sized, or one of the largest central laboratories, executives in these organizations recognize the high value of being named a preferred provider.
While obtaining preferred status may seem to be a standard of conducting business for the largest central labs, the reality is that many emerging and mid-sized central lab providers view PPAs as a “holy grail” and are still aspiring to put these difficult to achieve relationships in place.
Executives from our Diagnostics practice detail the six key selection categories to achieving preferred provider status across a handful of distinct areas of competition, including:
- Therapeutic Areas and Scientific Capabilities
- Geographies and Deployment Capability
- Data Quality and Management
- Operational Efficiency
For added insight on how each of the key selection categories can assist in earning preferred provider status, download the white paper below.